In particular, it has been reported in a meta-analysis that XRCC3 316A>G Thr241Met (rs1799794) is related with response to platinating agents, which highlights the prognostic value of XRCC3 Thr241Met polymorphism in patients with lung cancer. The gene discussed is XRCC3; the disease is lung cancer.